Acquisition of CORPAK MedSystems
Baird served as exclusive financial advisor to Halyard Health, Inc. on this transaction
AboutHalyard Health, Inc. (“Halyard” or the “Company”) (NYSE: HYH), recently completed the acquisition of CORPAK MedSystems (“Corpak”). The acquisition is an all cash transaction for a total consideration of $174 million, funded with a combination of current cash and Halyard's revolving credit facility.
Halyard is a medical technology company focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. Halyard is committed to addressing some of today's most important healthcare needs, such as preventing healthcare-associated infections and reducing the use of narcotics while helping patients move from surgery to recovery. Halyard's business segments - Surgical and Infection Prevention and Medical Devices - develop, manufacture and market clinically superior solutions that improve medical outcomes and business performance in more than 100 countries. Halyard is headquartered in Alpharetta, Georgia.
Corpak, a portfolio company of Linden Capital Partners, has a long history of innovating enteral access solutions to improve patient outcomes, safety and comfort. Corpak’s leading portfolio of nasogastric tubes complements Halyard's existing enteral feeding products and creates a complete offering of enteral feeding solutions for patients and caregivers. Corpak's sales for fiscal year 2015 totaled approximately $54 million. Corpak is headquartered in Buffalo Grove, Illinois.
For additional information about this transaction, please contact:
- May 2016
- Halyard Health, Inc
- Target Location
- North America
- Acquiror Location
- North America